Lin Cheng

机构：Anhui Medical University, Ruijin Hospital, Shanghai Sixth People's Hospital, Shanghai Institute of Hematology, Second Affiliated Hospital of Anhui Medical University, Shanghai Cell Therapy Research Institute · ORCID：0000-0002-3688-9863

发表论文 112 篇 · 总被引 5532 次 · h-index 33

代表论文

• Structure, function and drug discovery of GPCR signaling (2023 · Molecular Biomedicine · 被引 118)
• Target neutrophil heterogeneity and plasticity in cancer (2025 · Journal of Hematology & Oncology · 被引 29)
• Cryo-EM structure of small-molecule agonist bound delta opioid receptor-Gi complex enables discovery of biased compound (2024 · Nature Communications · 被引 21)
• Chlorogenic acid alleviates the development of severe acute pancreatitis by inhibiting NLPR3 Inflammasome activation via Nrf2/HO-1 signaling (2025 · International Immunopharmacology · 被引 13)
• Multi-omics uncovers immune-modulatory molecules in plasma contributing to resistance exercise-ameliorated locomotor disability after incomplete spinal cord injury (2025 · Genome Medicine · 被引 11)
• Benders decomposition for traveling salesman problem with drone: A space-time-state network perspective (2025 · Transportation Research Part C Emerging Technologies · 被引 7)